Investigators report the findings from a study assessing the impact of insomnia on clinical outcomes in patients with major depressive disorder.
While the relationship between current mood state and cognitive impairment is unclear, more severe depression has been linked to greater impairment.
Multimarker inflammatory biosignatures are expected to facilitate diagnosis and predict treatment outcomes for various central nervous system disorders, particularly Alzheimer disease and major depressive disorder.
The study provides strong evidence for the utility of resting-state fMRI measures in predicting the development of attentional or mood disorders in children.
This study highlights the importance of transdiagnostic approaches to psychiatry.
The risk factors for tardive dyskinesia in patients taking antipsychotics include age, comorbid diagnoses, and high medication dosages.
Cognitive behavioral therapy may improve a diverse array of depressive symptoms in patients with Parkinson disease.
Overall, in all patients with MDD, sleep ultradian cycle number was positively associated with REMS percentage, REMS duration, and REMS/NREMS ratio and negatively associated with REM latency.
Polygenic risk scores predict the progression from unipolar depression to bipolar or psychiatric disorders.